Extenuating symptoms is very important for malignant pericardial effusion.
作者信息
Gong Wenhui, Zhao Qiang
机构信息
1 Department of Cardiac Surgery, Ruijin Hospital of Shanghai Jiaotong University School of Medicine, Shanghai 200025, China ; 2 Department of Cardio-thoracic Surgery, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
出版信息
J Thorac Dis. 2015 Apr;7(4):E104. doi: 10.3978/j.issn.2072-1439.2015.04.16.
Abstract
摘要
相似文献
1
Extenuating symptoms is very important for malignant pericardial effusion.缓解症状对恶性心包积液非常重要。
J Thorac Dis. 2015 Apr;7(4):E104. doi: 10.3978/j.issn.2072-1439.2015.04.16.
2
Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis.CYFRA 21-1和癌胚抗原检测在识别肿瘤性心包炎的心包积液中的诊断效用。
Int J Biol Markers. 2005 Jan-Mar;20(1):43-49. doi: 10.5301/JBM.2008.318.
3
Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer.心包内注射顺铂用于治疗肺癌患者合并的大量恶性心包积液。
Lung Cancer. 1997 Mar;16(2-3):215-22. doi: 10.1016/s0169-5002(96)00631-9.
4
Pericardoscopy for primary management of pericardial effusion in cancer patients.
Eur J Cardiothorac Surg. 1999 Sep;16(3):287-91. doi: 10.1016/s1010-7940(99)00204-3.
5
Treatment of malignant pericardial effusion.恶性心包积液的治疗。
JAMA. 1994 Jul 6;272(1):59-64.
6
Clinical presentation and cytopathologic features of malignant pericardial cytology: a single institution analysis spanning a 29-year period.恶性心包细胞学的临床表现及细胞病理学特征：一项涵盖29年的单机构分析
J Am Soc Cytopathol. 2015 Jul-Aug;4(4):203-209. doi: 10.1016/j.jasc.2015.01.009. Epub 2015 Jan 30.
7
Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis.CYFRA 21-1和癌胚抗原检测在心包积液中对诊断肿瘤性心包炎的应用价值。
Int J Biol Markers. 2005 Jan-Mar;20(1):43-9.
8
Malignant pericardial effusion and pericardial tumor involvement secondary to cervical cancer.
Mil Med. 2013 Jan;178(1):e130-2. doi: 10.7205/MILMED-D-12-00314.
9
Differentiation malignant from benign pericardial effusion with diffusion-weighted MRI.用弥散加权 MRI 区分良、恶性心包积液。
Clin Radiol. 2019 Apr;74(4):325.e19-325.e24. doi: 10.1016/j.crad.2019.01.005. Epub 2019 Feb 6.
10
CT findings in patients with pericardial effusion: differentiation of malignant and benign disease.心包积液患者的 CT 表现：良恶性疾病的鉴别。
AJR Am J Roentgenol. 2010 Jun;194(6):W489-94. doi: 10.2214/AJR.09.2599.
本文引用的文献
1
Symptomatic malignant pericardial effusion due to advanced pericardial malignancies: a palliative approach.晚期心包恶性肿瘤所致有症状的恶性心包积液：一种姑息治疗方法。
J Thorac Dis. 2015 Apr;7(4):E102-3. doi: 10.3978/j.issn.2072-1439.2015.04.05.
2
Survival after surgical drainage of malignant pericardial effusion.恶性心包积液手术引流后的生存情况。
World J Surg. 2015 Jul;39(7):1767-72. doi: 10.1007/s00268-015-3025-5.
3
Palliative treatment for symptomatic malignant pericardial effusion†.有症状恶性心包积液的姑息治疗†
Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):1019-26. doi: 10.1093/icvts/ivu267. Epub 2014 Aug 20.
Zotero 插件